Dr. Banerjee Describes Practice-Changing MM Data Presented at ASH 2024 Blood Cancers Today 13:33 16 hours ago 29 Далее Скачать
Smoldering myeloma highlights from ASH 2024: the AQUILA study VJHemOnc – Video Journal of Hematology & HemOnc 2:49 4 days ago 78 Далее Скачать
IMWG Conference Series: Making Sense of Treatment ASH 2024 International Myeloma Foundation 1:30:57 1 day ago 331 Далее Скачать
24-hour Urine Testing Does Not Add Value to Myeloma Response Assessments | Rahul Banerjee | #ASH24 HealthTree Foundation for Multiple Myeloma 3:33 3 days ago 345 Далее Скачать
Replay: Discover the Latest Myeloma Research at ASH - Insights for Patients & Families International Myeloma Foundation 48:19 9 days ago 1 072 Далее Скачать
MCL updates from ASH 2024 and the key takeaways for community oncologists VJHemOnc – Video Journal of Hematology & HemOnc 1:39 10 days ago 243 Далее Скачать
Dr. C. Ola Landgren - ASH 2024 Sylvester Comprehensive Cancer Center 1:31 13 days ago 158 Далее Скачать
Dr. Juan Alderuccio - ASH 2024 Sylvester Comprehensive Cancer Center 0:59 13 days ago 129 Далее Скачать
ASH 2023 Multiple Myeloma Highlights – PERSEUS, IsKia, Bortezomib dosing, KarMMA-3 OncBrothers: Practice-Changing Cancer Discussions 16:43 1 year ago 2 699 Далее Скачать
ASH 2024: Dr. Fnu Amisha Discusses Predictive Markers After BCMA CAR T Therapy in RRMM Patients Moffitt Cancer Center 2:16 11 days ago 33 Далее Скачать
Post-CAR-T Driving Restrictions after Week 4 In Myeloma Appear Unnecessary | Rahul Banerjee | #ASH24 HealthTree Foundation for Multiple Myeloma 3:54 3 days ago 131 Далее Скачать
ASH 2024: Nelli Bejanyan, MD on Donor Gamma Delta T-Cell Therapy to Prevent AML Relapse Moffitt Cancer Center 2:59 7 days ago 31 Далее Скачать
ASH 2024: Mark Meads, PhD Presented Immune Evasion Linked to Daratumumab Resistance in NDMM Moffitt Cancer Center 6:31 9 days ago 25 Далее Скачать
Exciting ALL updates from ASH 2024 VJHemOnc – Video Journal of Hematology & HemOnc 5:07 10 days ago 140 Далее Скачать
ASH 2024: Jeremy DiGennaro, DO on Pacritinib, Momelotinib Use and Outcomes in Myelofibrosis Moffitt Cancer Center 4:34 7 days ago 19 Далее Скачать
ASH 2024: Drs. David Sallman and Jeff Lancet Discuss Measurable Residual Disease in AML and MDS Moffitt Cancer Center 4:02 11 days ago 39 Далее Скачать
